Login / Signup

Introducing an important therapy for obesity to primary care: once-weekly subcutaneous semaglutide 2.4 mg.

Janine V KyrillosPatrick M O'NeilSean Wharton
Published in: Postgraduate medicine (2023)
Keyphrases
  • primary care
  • insulin resistance
  • metabolic syndrome
  • weight loss
  • high fat diet induced
  • type diabetes
  • weight gain
  • general practice
  • physical activity